Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2009
03/18/2009CN100469364C Antiviral medicine, preparation method and application thereof
03/18/2009CN100469363C Therapeutic combinations of fatty acids
03/18/2009CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/18/2009CN100469355C Nutritional supplements and methods of using same
03/17/2009US7504483 α-β C4BP-type recombinant heteromultimeric proteins
03/17/2009US7504482 Recombinant soluble Fc receptors
03/17/2009US7504434 3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-dimer; viricide; influenza A or B infection, parainfluenza, mumps or Newcastle disease, myxovirus infections; stability; long time in lungs
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/17/2009US7504254 Hybridomas; monoclonal antibodies do not cross-react with host tissue polysialic acid and pose minimal risk of autoimmune activity; vaccines; mimetics
03/17/2009US7504247 2-O sulfatase compositions and methods of degradation therewith
03/17/2009US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases
03/17/2009US7504224 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy
03/17/2009US7504111 Protein from gonococcus (Neisseria gonorrhoeae), including a specific amino acid sequence; antigens for vaccines, immunogenic compositions, and/or diagnostics; useful for distinguishing between gonococcus and meningococcus
03/17/2009CA2502731C Sustained release composition for oral administration of drugs
03/17/2009CA2380205C Novel bicyclonucleoside analogues
03/17/2009CA2355712C Antiviral nucleoside analogues
03/17/2009CA2319094C Antimicrobial peptides
03/13/2009CA2597878A1 Capsid protein and use therefore
03/12/2009WO2009033095A2 Humanized pai-1 antibodies
03/12/2009WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
03/12/2009WO2009032406A1 Dentifrice compositions for treating xerostomia
03/12/2009WO2009032326A1 New tetracycline derivatives as antiinfective agents
03/12/2009WO2009032244A1 Method for the treatment of hiv/aids infection using acyclovir in identified subjects
03/12/2009WO2009032180A1 Phosphadiazine hcv polymerase inhibitors iv
03/12/2009WO2009032179A1 Phosphadiazine hcv polymerase inhibitors iii and vi
03/12/2009WO2009032177A1 Phosphadiazine hcv polymerase inhibitors i and ii
03/12/2009WO2009032176A1 Phosphadiazine hcv polymerase inhibitors v
03/12/2009WO2009032125A1 2,3-substituted azaindole derivatives for treating viral infections
03/12/2009WO2009032124A1 Substituted indole derivatives and methods of use thereof
03/12/2009WO2009032116A1 2, 3-substituted indole derivatives for treating viral infections
03/12/2009WO2009031918A1 Apolactoferrin compositions and methods of the use thereof for treating viral hepatitis c
03/12/2009WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN
03/12/2009WO2009031644A1 Antifungal pharmaceutical composition
03/12/2009WO2009031643A1 Antifungal composition
03/12/2009WO2009031642A1 Pharmaceutical composition
03/12/2009WO2009031576A1 Process for producing valacyclovir hydrochloride crystal
03/12/2009WO2009031333A1 Medium for insects belonging to sarcophagidae and calliphoridae in the ovary development stage and egg laying stage, method of feeding insects belonging to sarcophagidae and calliphoridae and insects for medical use
03/12/2009WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists
03/12/2009WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists
03/12/2009WO2009030978A2 Conformers of bacterial adhesins
03/12/2009WO2009030890A1 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma
03/12/2009WO2009030773A1 Pharmaceutical composition effective against biofilms
03/12/2009WO2009030684A2 Reduction of concomitant infections in pigs by the use of pcv2 antigen
03/12/2009WO2009030676A2 Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients of at least 40 years of age
03/12/2009WO2009030107A1 Benzenesulfonamido methylene substituted mercapto pyrrolidine carbapenem derivatives
03/12/2009WO2009030106A1 7-(4-oximino-3-amino-1-piperidyl)quinolinecarboxylic acid derivatives and their preparation methods
03/12/2009WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
03/12/2009WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
03/12/2009WO2009030040A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria
03/12/2009WO2009029998A1 Retrometabolic compounds
03/12/2009WO2009005798A8 Antifungal formulation and method of preparation
03/12/2009WO2009000853A3 Combination formulations comprising darunavir and etravirine
03/12/2009WO2008149244A3 Compositions and methods comprising analogues of radicicol a
03/12/2009WO2008139402A4 A method of inhibiting hiv replication
03/12/2009WO2008135446A3 Klebsiella antigens
03/12/2009WO2008113557A3 Anti-infective agents
03/12/2009WO2008073444A3 Phou (perf), a persistence switch involved in persister formation as a drug target for persister bacteria
03/12/2009WO2007129274A9 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350.
03/12/2009WO2007016134A9 BICYCLIC 6-ALKYLIDENE-PENEM B-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC
03/12/2009US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells
03/12/2009US20090069435 Bridged polycyclic compound based compositions for topical applications for pets
03/12/2009US20090069406 Analogs of tetramic acid
03/12/2009US20090069357 Deuterium-enriched iclaprim
03/12/2009US20090069344 Modulators of hcv replication
03/12/2009US20090069339 Deuterium-enriched ciprofloxacin
03/12/2009US20090069336 Pyrimidothiophene compounds
03/12/2009US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity
03/12/2009US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections
03/12/2009US20090069314 Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods
03/12/2009US20090069286 Deuterium-enriched aztreonam
03/12/2009US20090069248 Substrate peptide sequences for plague plasminogen activator and uses thereof
03/12/2009US20090069225 Somatostatin analogues
03/12/2009US20090069219 Deuterium-enriched telavancin
03/12/2009US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
03/12/2009US20090068636 Viral protein
03/12/2009US20090068283 Silver-based inorganic antimicrobial agent and antimicrobial product
03/12/2009US20090068280 Controlled Release Interferon Drug Products and Treatment of HCV Infections Using Same
03/12/2009US20090068257 Betulonic and betulinic acid derivatives
03/12/2009US20090068254 Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant
03/12/2009US20090068253 Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione
03/12/2009US20090068248 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
03/12/2009US20090068232 Attenuated mycoplasma gallisepticum strains
03/12/2009US20090068230 Enterohemorrhagic escherichia coli vaccine
03/12/2009US20090068229 Modified surface antigen
03/12/2009US20090068228 Vaccine; effective combination of pertussis filamentous hemagglutinin (FHA), pertactin (PRN, 69K-OMP), pertussis fimbriae (FIM) and pertussis toxin (PT); industrial scale purification
03/12/2009US20090068226 Bacterial superantigen vaccines
03/12/2009US20090068224 Method to identify polypeptide toll-like receptor (tlr) ligands
03/12/2009US20090068223 Combination vaccine comprising an attenuated bovine viral diarrhea virus
03/12/2009US20090068221 Virus-like particles as vaccines for paramyxovirus
03/12/2009US20090068217 Recombinant vaccine for preventing and treating porcine atrophic rhinitis
03/12/2009US20090068216 Modified surface antigen
03/12/2009US20090068215 Herpes simplex virus mutant icp0 protein
03/12/2009US20090068214 Methods and Compositions for Producing an Enhanced Immune Response to a Human Papillomavirus Immunogen
03/12/2009US20090068213 Immunogenic composition for early detection of dengue virus
03/12/2009US20090068212 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans
03/12/2009US20090068201 Methods of treatment using antibodies to neutrokine-alpha
03/12/2009US20090068191 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of the Pseudomonas Aeruginosa IATS 011 Serotype
03/12/2009US20090068189 Monoclonal Antibody to Human TGF-Beta Induced Gene-H3 and Use Thereof
03/12/2009US20090068179 Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors
03/12/2009US20090068168 Substituted amino alcohols
1 ... 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 ... 1798